Literature DB >> 21843517

Impact of divalent metal ions on regulation of adenylyl cyclase isoforms by forskolin analogs.

Miriam Erdorf1, Tung-Chung Mou, Roland Seifert.   

Abstract

Mammalian membranous adenylyl cyclases (mACs) play an important role in transmembrane signalling events in almost every cell and represent an interesting drug target. Forskolin (FS) is an invaluable research tool, activating AC isoforms 1-8. However, there is a paucity of AC isoform-selective FS analogs. Therefore, we examined the effects of FS and six FS derivatives on recombinant ACs 1, 2 and 5, representing members of different mAC families. Correlations of the pharmacological properties of the different AC isoforms revealed pronounced differences between ACs 1, 2 and 5. Additionally, potencies and efficacies of FS derivatives changed for any given AC isoform, depending on the metal ion, Mg(2+) or Mn(2+). The most striking effects of Mg(2+) and Mn(2+) on the diterpene profile were observed for AC2 where the large inhibitory effect of BODIPY-FS in the presence of Mg(2+) was considerably reduced in the presence of Mn(2+). Sequence alignment and docking experiments confirmed an exceptional position of AC2 compared to ACs 1 and 5 with respect to the structural environment of the catalytic core and cation-dependent diterpene effects. In conclusion, mAC isoforms 1, 2 and 5 exhibit a distinct pharmacological diterpene profile, depending on the divalent cation present. mAC crystal structures and modelling/docking studies provided an explanation for the pharmacological differences between the AC isoforms. Our study constitutes an important step towards the development of isoform-specific diterpenes exhibiting stimulatory or inhibitory effects.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21843517      PMCID: PMC5360100          DOI: 10.1016/j.bcp.2011.07.099

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  30 in total

1.  Pharmacological characterization of adenylyl cyclase isoforms in rabbit kidney membranes.

Authors:  Miriam Erdorf; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-29       Impact factor: 3.000

2.  Identification of a forskolin-like molecule in human renal cysts.

Authors:  William C Putnam; Sarah M Swenson; Gail A Reif; Darren P Wallace; George M Helmkamp; Jared J Grantham
Journal:  J Am Soc Nephrol       Date:  2007-01-24       Impact factor: 10.121

3.  Reconstitution of beta2-adrenoceptor-GTP-binding-protein interaction in Sf9 cells--high coupling efficiency in a beta2-adrenoceptor-G(s alpha) fusion protein.

Authors:  R Seifert; T W Lee; V T Lam; B K Kobilka
Journal:  Eur J Biochem       Date:  1998-07-15

4.  Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphate.

Authors:  Tung-Chung Mou; Andreas Gille; David A Fancy; Roland Seifert; Stephen R Sprang
Journal:  J Biol Chem       Date:  2004-12-09       Impact factor: 5.157

5.  Effect of divalent ions on basal and hormone-activated renal adenylate cyclase/cyclic AMP system.

Authors:  H Wald; M M Popovtzer
Journal:  Miner Electrolyte Metab       Date:  1984

6.  Broad specificity of mammalian adenylyl cyclase for interaction with 2',3'-substituted purine- and pyrimidine nucleotide inhibitors.

Authors:  Tung-Chung Mou; Andreas Gille; Srividya Suryanarayana; Mark Richter; Roland Seifert; Stephen R Sprang
Journal:  Mol Pharmacol       Date:  2006-06-09       Impact factor: 4.436

7.  Type-specific regulation of adenylyl cyclase. Selective pharmacological stimulation and inhibition of adenylyl cyclase isoforms.

Authors:  T Onda; Y Hashimoto; M Nagai; H Kuramochi; S Saito; H Yamazaki; Y Toya; I Sakai; C J Homcy; K Nishikawa; Y Ishikawa
Journal:  J Biol Chem       Date:  2001-10-15       Impact factor: 5.157

8.  Differential interactions of the catalytic subunits of adenylyl cyclase with forskolin analogs.

Authors:  Cibele Pinto; Melanie Hübner; Andreas Gille; Mark Richter; Tung-Chung Mou; Stephen R Sprang; Roland Seifert
Journal:  Biochem Pharmacol       Date:  2009-04-02       Impact factor: 5.858

9.  The positive inotropic-acting forskolin, a potent adenylate cyclase activator.

Authors:  H Metzger; E Lindner
Journal:  Arzneimittelforschung       Date:  1981

10.  The C1 homodimer of adenylyl cyclase binds nucleotides with high affinity but possesses exceedingly low catalytic activity.

Authors:  Srividya Suryanarayana; Cibele Pinto; Tung-Chung Mou; Mark Richter; Gerald H Lushington; Roland Seifert
Journal:  Neurosci Lett       Date:  2009-09-27       Impact factor: 3.046

View more
  9 in total

Review 1.  Inhibitors of membranous adenylyl cyclases.

Authors:  Roland Seifert; Gerald H Lushington; Tung-Chung Mou; Andreas Gille; Stephen R Sprang
Journal:  Trends Pharmacol Sci       Date:  2011-11-17       Impact factor: 14.819

2.  Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds.

Authors:  Cameron S Brand; Harrison J Hocker; Alemayehu A Gorfe; Claudio N Cavasotto; Carmen W Dessauer
Journal:  J Pharmacol Exp Ther       Date:  2013-09-04       Impact factor: 4.030

3.  Development of a high-throughput screening paradigm for the discovery of small-molecule modulators of adenylyl cyclase: identification of an adenylyl cyclase 2 inhibitor.

Authors:  Jason M Conley; Cameron S Brand; Amy S Bogard; Evan P S Pratt; Ruqiang Xu; Gregory H Hockerman; Rennolds S Ostrom; Carmen W Dessauer; Val J Watts
Journal:  J Pharmacol Exp Ther       Date:  2013-09-05       Impact factor: 4.030

4.  Adenylyl cyclase 2 selectively couples to E prostanoid type 2 receptors, whereas adenylyl cyclase 3 is not receptor-regulated in airway smooth muscle.

Authors:  Amy S Bogard; Piyatilake Adris; Rennolds S Ostrom
Journal:  J Pharmacol Exp Ther       Date:  2012-05-22       Impact factor: 4.030

5.  Impairment of adenylyl cyclase 2 function and expression in hypoxanthine phosphoribosyltransferase-deficient rat B103 neuroblastoma cells as model for Lesch-Nyhan disease: BODIPY-forskolin as pharmacological tool.

Authors:  Liz Kinast; Juliane von der Ohe; Heike Burhenne; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-03       Impact factor: 3.000

Review 6.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 7.  Physiological roles of mammalian transmembrane adenylyl cyclase isoforms.

Authors:  Katrina F Ostrom; Justin E LaVigne; Tarsis F Brust; Roland Seifert; Carmen W Dessauer; Val J Watts; Rennolds S Ostrom
Journal:  Physiol Rev       Date:  2021-10-26       Impact factor: 37.312

Review 8.  Molecular motions as a drug target: mechanistic simulations of anthrax toxin edema factor function led to the discovery of novel allosteric inhibitors.

Authors:  Elodie Laine; Leandro Martínez; Daniel Ladant; Thérèse Malliavin; Arnaud Blondel
Journal:  Toxins (Basel)       Date:  2012-07-31       Impact factor: 4.546

Review 9.  Cardiac cAMP: production, hydrolysis, modulation and detection.

Authors:  Cédric Boularan; Céline Gales
Journal:  Front Pharmacol       Date:  2015-10-01       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.